Transitional Insight into the RNA-Based Oligonucleotides in Cancer Treatment
Applied Biochemistry and Biotechnology · 2024
DOI: 10.1007/s12010-023-04597-5 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Applied Biochemistry and Biotechnology, 2024. Verfasst von Hamed Tabasi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. Hauptthemen laut MEDLINE: MicroRNAs, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 160 Literaturangaben. Gefördert von: Mashhad University of Medical Sciences.
Abstract (Originalsprache)
Conventional cancer therapies with chemodrugs suffer from various disadvantages, such as irreversible side effects on the skin, heart, liver, and nerves with even fatal consequences. RNA-based therapeutic is a novel technology which offers great potential as non-toxic, non-infectious, and well-tolerable platform. Herein, we introduce different RNA-based platforms with a special focus on siRNA, miRNA, and mRNA applications in cancer treatment in order to better understand the details of their therapeutic effects. Of note, the co-delivery of RNAs with other distinct RNA or drugs has provided safe, efficient, and novel treatment modalities for cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
- Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran.
- Biomedicine Department, Aarhus University, Aarhus, Denmark.
- Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran. ramezanim@mums.ac.ir.
- Department of Pharmaceutical Biotechnology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. ramezanim@mums.ac.ir.
Förderung
- Mashhad University of Medical Sciences
Zitieren
APA
Tabasi, H., Mollazadeh, S., Fazeli, E., Abnus, K., Taghdisi, S. M., Ramezani, M., & Alibolandi, M. (2024). Transitional Insight into the RNA-Based Oligonucleotides in Cancer Treatment. Applied Biochemistry and Biotechnology. https://doi.org/10.1007/s12010-023-04597-5
Vancouver
Tabasi H, Mollazadeh S, Fazeli E, Abnus K, Taghdisi SM, Ramezani M, et al. Transitional Insight into the RNA-Based Oligonucleotides in Cancer Treatment. Applied Biochemistry and Biotechnology. 2024. doi:10.1007/s12010-023-04597-5
BibTeX
@article{Tabasi2024,
author = {Tabasi, Hamed and Mollazadeh, Samaneh and Fazeli, Elham and Abnus, Khalil and Taghdisi, Seyed Mohammad and Ramezani, Mohammad and Alibolandi, Mona},
title = {Transitional Insight into the RNA-Based Oligonucleotides in Cancer Treatment},
journal = {Applied Biochemistry and Biotechnology},
year = {2024},
doi = {10.1007/s12010-023-04597-5}
}
EUVIMED